Tokyo Tape
Sign in
← Santen Pharmaceutical

Quarterly report · Q3

4536.TEDINET S100Q4MU
Period2022-04-01 → 2022-12-31
Filed2023-02-09
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥199.8bn2022-04-01 → 2022-12-31Cons.Revenue IFRS
Revenue¥70.9bn2022-10-01 → 2022-12-31dCons.Revenue IFRS
Revenue¥266.3bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥195.8bn2021-04-01 → 2021-12-31Cons.Revenue IFRS
Revenue¥67.0bn2021-10-01 → 2021-12-31dCons.Revenue IFRS
Operating income−¥10.1bn2022-04-01 → 2022-12-31Cons.Operating profit loss IFRS
Operating income¥8.9bn2022-10-01 → 2022-12-31dCons.Operating profit loss IFRS
Operating income¥26.4bn2021-04-01 → 2021-12-31Cons.Operating profit loss IFRS
Operating income¥7.6bn2021-10-01 → 2021-12-31dCons.Operating profit loss IFRS
Profit before tax−¥11.6bn2022-04-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax¥7.5bn2022-10-01 → 2022-12-31dCons.Profit loss before tax IFRS
Profit before tax¥35.6bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥25.7bn2021-04-01 → 2021-12-31Cons.Profit loss before tax IFRS
Profit before tax¥7.3bn2021-10-01 → 2021-12-31dCons.Profit loss before tax IFRS
Net income (owners)−¥16.1bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥6.0bn2022-10-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥27.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥19.3bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥5.0bn2021-10-01 → 2021-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income−¥16.1bn2022-04-01 → 2022-12-31Cons.Profit loss IFRS
Net income¥5.9bn2022-10-01 → 2022-12-31dCons.Profit loss IFRS
Net income¥19.3bn2021-04-01 → 2021-12-31Cons.Profit loss IFRS
Net income¥5.0bn2021-10-01 → 2021-12-31dCons.Profit loss IFRS
Total assets¥420.1bnat 2022-12-31Cons.Assets IFRS
Total assets¥460.0bnat 2022-03-31Cons.Assets IFRS
Total assets¥429.6bnat 2021-12-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥119.9bnat 2022-12-31Cons.Liabilities IFRS
Total liabilities¥123.1bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥300.3bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥336.8bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥320.8bnat 2021-12-31Cons.Equity IFRS
Net assets / equity¥309.6bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥300.9bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥337.5bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥321.4bnat 2021-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥61.2bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥83.0bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥67.8bnat 2021-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥62.9bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥28.5bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥46.0bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥31.2bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥23.6bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥35.2bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥23.2bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥28.0bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥5.6bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥4.1bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-41.132022-04-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥15.492022-10-01 → 2022-12-31dCons.Basic earnings loss per share IFRS
EPS (basic)¥68.072021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥48.392021-04-01 → 2021-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥12.62021-10-01 → 2021-12-31dCons.Basic earnings loss per share IFRS
EPS (diluted)¥-41.132022-04-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥15.462022-10-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥67.972021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥48.322021-04-01 → 2021-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥12.592021-10-01 → 2021-12-31dCons.Diluted earnings loss per share IFRS
Equity ratio71.6%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio73.4%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio74.8%at 2021-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 626
ItemContextValueUnit
Profit loss before tax IFRSCurrentYTDDuration-11593000000JPY
Income tax expense IFRSPrior1YTDDuration6377000000JPY
Income tax expense IFRSCurrentYTDDuration4495000000JPY
Profit loss IFRSPrior1YTDDuration19296000000JPY
Profit loss IFRSCurrentYTDDuration-16088000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration-960000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration2245000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration4183000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration6598000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration284000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration581000000JPY
Other comprehensive income IFRSPrior1YTDDuration3507000000JPY
Other comprehensive income IFRSCurrentYTDDuration9424000000JPY
Comprehensive income IFRSPrior1YTDDuration22803000000JPY
Comprehensive income IFRSCurrentYTDDuration-6664000000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration19349000000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration-16064000000JPY
Profit loss attributable to non controlling interests IFRSPrior1YTDDuration-53000000JPY
Profit loss attributable to non controlling interests IFRSCurrentYTDDuration-24000000JPY
Profit loss IFRSPrior1YTDDuration19296000000JPY
Profit loss IFRSCurrentYTDDuration-16088000000JPY
Comprehensive income attributable to owners of parent IFRSPrior1YTDDuration22898000000JPY
Comprehensive income attributable to owners of parent IFRSCurrentYTDDuration-6646000000JPY
Comprehensive income attributable to non controlling interests IFRSPrior1YTDDuration-96000000JPY
Comprehensive income attributable to non controlling interests IFRSCurrentYTDDuration-18000000JPY
Comprehensive income IFRSPrior1YTDDuration22803000000JPY
Comprehensive income IFRSCurrentYTDDuration-6664000000JPY
Basic earnings loss per share IFRSPrior1YTDDuration48.39
Basic earnings loss per share IFRSCurrentYTDDuration-41.13
Diluted earnings loss per share IFRSPrior1YTDDuration48.32
Diluted earnings loss per share IFRSCurrentYTDDuration-41.13
Revenue IFRSPrior1QuarterDuration67042000000JPY
Revenue IFRSCurrentQuarterDuration70871000000JPY
Cost of sales IFRSPrior1QuarterDuration29837000000JPY
Cost of sales IFRSCurrentQuarterDuration29548000000JPY
Gross profit IFRSPrior1QuarterDuration37205000000JPY
Gross profit IFRSCurrentQuarterDuration41323000000JPY
Selling general and administrative expenses IFRSPrior1QuarterDuration20671000000JPY
Selling general and administrative expenses IFRSCurrentQuarterDuration23206000000JPY
Research and development expenditure recognized as expense during period IFRSPrior1QuarterDuration6464000000JPY
Research and development expenditure recognized as expense during period IFRSCurrentQuarterDuration7415000000JPY
Amortization on intangible assets associated with products IFRSPrior1QuarterDuration2468000000JPY
Amortization on intangible assets associated with products IFRSCurrentQuarterDuration2059000000JPY
Other income IFRSPrior1QuarterDuration116000000JPY
Other income IFRSCurrentQuarterDuration262000000JPY
Other expenses IFRSPrior1QuarterDuration143000000JPY
Other expenses IFRSCurrentQuarterDuration32000000JPY
Operating profit loss IFRSPrior1QuarterDuration7575000000JPY
Operating profit loss IFRSCurrentQuarterDuration8874000000JPY
Finance income IFRSPrior1QuarterDuration540000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-10-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2021-10-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2022-10-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass